FibroBiologics Inc. Commo...

1.15
-0.11 (-8.73%)
At close: Mar 03, 2025, 3:59 PM
1.15
-0.43%
Pre-market: Mar 04, 2025, 08:53 AM EST

FibroBiologics Common Stock Income Statement

Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue 437K 94K n/a n/a
Gross Profit -437K -94K n/a n/a
Operating Income -8.89M -4.47M -1.58M -1.17M
Interest Income n/a n/a n/a n/a
Pretax Income -16.48M -5.12M -1.58M -1.17M
Net Income -16.48M -5.12M -1.58M -1.17M
Selling & General & Admin 6.52M 3.23M 1.06M 500K
Research & Development 2.37M 1.15M 521K 669K
Other Expenses n/a n/a n/a n/a
Operating Expenses 8.89M 4.37M 1.58M 1.17M
Interest Expense 147K 654K 4K n/a
Selling & Marketing Expenses 685K -94K n/a n/a
Cost & Expenses 8.89M 4.47M 1.58M 1.17M
Income Tax n/a n/a n/a n/a
Shares Outstanding (Basic) 32.49M 32.49M 32.49M 8.75M
Shares Outstanding (Diluted) 28.23M 32.49M 32.49M 8.75M
EPS (Basic) -0.59 -0.16 -0.05 -0.13
EPS (Diluted) -0.68 -0.16 -0.05 -0.13
EBITDA -15.9M -4.37M -1.58M n/a
Depreciation & Amortization 437K 94K n/a 1.17M